Form 8-K - Current report:
SEC Accession No. 0001193125-22-156798
Filing Date
2022-05-23
Accepted
2022-05-23 07:18:36
Documents
30
Period of Report
2022-05-23
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d308906d8k.htm   iXBRL 8-K 34123
2 EX-99.1 d308906dex991.htm EX-99.1 17919
6 GRAPHIC g308906ex99_1p10g1.jpg GRAPHIC 138847
7 GRAPHIC g308906ex99_1p11g1.jpg GRAPHIC 255185
8 GRAPHIC g308906ex99_1p12g1.jpg GRAPHIC 249158
9 GRAPHIC g308906ex99_1p13g1.jpg GRAPHIC 204434
10 GRAPHIC g308906ex99_1p14g1.jpg GRAPHIC 212963
11 GRAPHIC g308906ex99_1p15g1.jpg GRAPHIC 244835
12 GRAPHIC g308906ex99_1p16g1.jpg GRAPHIC 191245
13 GRAPHIC g308906ex99_1p17g1.jpg GRAPHIC 165240
14 GRAPHIC g308906ex99_1p1g1.jpg GRAPHIC 164394
15 GRAPHIC g308906ex99_1p2g1.jpg GRAPHIC 425192
16 GRAPHIC g308906ex99_1p3g1.jpg GRAPHIC 273852
17 GRAPHIC g308906ex99_1p4g1.jpg GRAPHIC 221273
18 GRAPHIC g308906ex99_1p5g1.jpg GRAPHIC 244731
19 GRAPHIC g308906ex99_1p6g1.jpg GRAPHIC 287402
20 GRAPHIC g308906ex99_1p7g1.jpg GRAPHIC 194136
21 GRAPHIC g308906ex99_1p8g1.jpg GRAPHIC 245034
22 GRAPHIC g308906ex99_1p9g1.jpg GRAPHIC 169688
  Complete submission text file 0001193125-22-156798.txt   5539686

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cnce-20220523.xsd EX-101.SCH 2875
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cnce-20220523_lab.xml EX-101.LAB 17995
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cnce-20220523_pre.xml EX-101.PRE 11274
24 EXTRACTED XBRL INSTANCE DOCUMENT d308906d8k_htm.xml XML 3358
Mailing Address 65 HAYDEN AVENUE SUITE 3000N LEXINGTON MA 02421
Business Address 65 HAYDEN AVENUE SUITE 3000N LEXINGTON MA 02421 781-860-0045
CONCERT PHARMACEUTICALS, INC. (Filer) CIK: 0001367920 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36310 | Film No.: 22949581
SIC: 2834 Pharmaceutical Preparations